In: Bioinformatics, 2016, vol. 32, no. 4, p. 481-489
|
In: Biomedical Engineering / Biomedizinische Technik, 2017, vol. 62, no. s1, p. s32-s36
|
In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 7, p. 1425-1434
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2015, vol. 42, no. 1, p. 128-137
|
In: Flow, Turbulence and Combustion, 2015, vol. 94, no. 4, p. 879-879
|
In: Brain, 2016, vol. 139, no. 5, p. 1587-1604
|
In: Experiments in Fluids, 2015, vol. 56, no. 5, p. 1-16
|
In: Journal of Radioanalytical and Nuclear Chemistry, 2015, vol. 305, no. 3, p. 769-775
|
In: Scientific Reports, 2020, vol. 10, no. 1, p. 6374
Bulimia nervosa (BN) shares central features with substance-related and addictive disorders. The metabotropic glutamate receptor subtype 5 (mGlu5) plays an important role in addiction. Based on similarities between binge eating and substance-related and addictive disorders, we investigated mGlu5 in vivo in 15 female subjects with BN and 15 matched controls. We measured mGlu5 distribution...
|
In: Scientific Reports, 2020, vol. 10, no. 1, p. 7078
Immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), have resulted in unprecedented improvements in survival for patients with lung cancer. Nonetheless, not all patients benefit equally and many issues remain unresolved, including the mechanisms of action and the possible effector function of immune cells from non-lymphoid lineages. The purpose of this...
|